返回
mRNA-Based Genetic Reprogramming
DOI:10.1016/j.ymthe.2018.12.009.png)
摘要
En 中文
The discovery that ordinary skin cells can be turned into pluripotent stem cells by the forced expression of defined factors has raised hopes that personalized regenerative treatments based on immunologically compatible material derived from a patient's own cells might be realized in the not-too-distant future. A major barrier to the clinical use of induced pluripotent stem cells (iPSCs) was initially presented by the need to employ integrating viral vectors to express the factors that induce an embryonic gene expression profile, which entails potentially oncogenic alteration of the normal genome. Several non-integrating reprogramming systems have been developed over the last decade to address this problem. Among these techniques, mRNA reprogramming is the most unambiguously ootprint-free, most productive, and perhaps the best suited to clinical production of stem cells. Herein, we discuss the origins of the mRNA-based reprogramming system, its benefits and drawbacks, recent technical improvements that simplify its application, and the status of current efforts to industrialize this approach to mass-produce human stem cells for the clinic.
Keyword:
PLURIPOTENT STEM-CELLS
HUMAN FIBROBLASTS
TRANSFECTION
GENERATION
INDUCTION
CAPACITY
RECEPTOR
VECTOR
DIFFERENTIATION
RECOGNITION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
12
论文数:
10.0K
被引数:
3.0W
机构
暂无机构信息
引用论文
Whole-genome mutational burden analysis of three pluripotency induction methods
NATURE COMMUNICATIONS
IF15.7
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability将假尿苷掺入mRNA可产生具有增强的翻译能力和生物稳定性的优异非免疫原性载体

